Mar 30, 2021
Site-Perspectives on Patient Engagement: Solutions for NASH Trials
Keeping track of patients in clinical trials has always been challenging for sites and sponsors. However, the COVID-19 pandemic has taken the challenge of patient engagement to new levels. Patients with fatty liver disorders such as nonalcoholic steatohepatitis (NASH) present numerous obstacles to program compliance in the best of times.
